Evaluation: finalised, SWD (2017)9 and SWD (2017)10, 10 January 2017, follow-up Communication: COM (2017)12, 10 January 2017
Commission Directive 2017/164 (Fourth list of Indicative Occupational Exposure Limit Values) adopted in January 2017
Commission Directives (technical updates): 2019/1832 (Personal Protective Equipment); 2019/1833 (Biological Agents) and 2019/1834 (Medical treatment on Board Vessels) adopted in October 2019
The evaluation of 24 EU Occupational Safety and Health Directives (i.e. the Framework Directive 89/391/EEC and 23 related Directives) confirmed that the legislative framework meets its ambition to adequately protect workers.
It concluded that the overall structure of the EU occupational safety and health acquis, consisting of a goal-oriented Framework Directive complemented by specific Directives, is generally effective and fit-for-purpose. However, it pointed to specific provisions of related Directives that have become outdated or obsolete.
Three Directives updated existing Directives to remove or update outdated provisions, also simplifying and reducing administrative burden for businesses and enforcement agencies while maintaining or improving workers’ protection. It concerns Directives 2019/1832 (Personal Protective Equipment); 2019/1833 (Biological Agents) and 2019/1834 (Medical treatment on Board Vessels).
In addition, EU-wide limit values for chemicals promote upwards levels of protection throughout the EU, contributing to an improved level playing field for businesses and help companies operating across borders thus saving costs. In light of the outcome of the ex-post evaluation, the Commission continues revising existing and establishing further occupational (binding and indicative) exposure limit values.
Commission Directive 2017/164 (Fourth list of Indicative Occupational Exposure Limit Values) adopted in October 2019 introduces a new list of indicative occupational exposure limit values (IOELVs) at EU level that Member States are required to transpose into national legislations. IOELVs set threshold levels of exposure below which, in general, no detrimental effects are expected for any given chemical agent after short-term or daily exposure over a working lifetime.
A full quantification of costs or benefits of EU OSH Directives was not possible given data limitations.
However, as to the benefits of reduced levels of work related accidents and ill-health, literature studies suggest that there is indeed a business case for occupational health and safety interventions. Further data from e.g. the International Social Security Association assessed the return on prevention index for investments in occupational health and safety to be 2.2. However, the evaluation could not quantify the benefits generated by the EU framework distinct from Member State legislation already in place or with more extensive coverage or providing a higher level of protection.
As to the costs of the EU occupational health and safety framework, the evaluation confirmed that on the basis of the available information, administrative and substantive compliance costs vary considerably across Member States and are presumed to be higher per employee in SMEs. The way in which Member States have transposed the EU occupational safety and health Directives varies considerably across Member States. Compliance costs therefore vary and cannot be easily dissociated from more detailed national requirements.
The three Directives (Directives 2019/1832 (Personal Protective Equipment); 2019/1833 (Biological Agents) and 2019/1834 (Medical treatment on Board Vessels) adopted in October 2019) seek also to simplify and reduce administrative burden for businesses and enforcement agencies while maintaining or improving workers’ protection. They remove obsolete provisions, add clarifications, update and restructure the annexes, and better align the provisions with more recent EU legislation.
Commission Directive 2017/164 (Fourth list of Indicative Occupational Exposure Limit Values) introduces a new list of indicative occupational exposure limit values (IOELVs) at EU level that Member States are required to transpose into national legislations. They constitute European objectives to assist employers in determining and assessing risks.